Mechanisms of the epithelial–mesenchymal transition by TGF-β MK Wendt, TM Allington, WP Schiemann Future Oncology 5 (8), 1145-1168, 2009 | 407 | 2009 |
Phosphoproteins in extracellular vesicles as candidate markers for breast cancer IH Chen, L Xue, CC Hsu, JSP Paez, L Pan, H Andaluz, MK Wendt, ... Proceedings of the National Academy of Sciences 114 (12), 3175-3180, 2017 | 385 | 2017 |
Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression MK Wendt, M Tian, WP Schiemann Cell and tissue research 347 (1), 85-101, 2012 | 270 | 2012 |
Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer MK Wendt, MA Taylor, BJ Schiemann, WP Schiemann Molecular biology of the cell 22 (14), 2423-2435, 2011 | 243 | 2011 |
Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression MK Wendt, JA Smith, WP Schiemann Oncogene 29 (49), 6485-6498, 2010 | 229 | 2010 |
STAT3 and epithelial–mesenchymal transitions in carcinomas MK Wendt, N Balanis, CR Carlin, WP Schiemann Jak-stat 3 (2), e28975, 2014 | 223 | 2014 |
Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis MK Wendt, WP Schiemann Breast cancer research 11, 1-16, 2009 | 206 | 2009 |
Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease NP Zimmerman, RA Vongsa, MK Wendt, MB Dwinell Inflammatory bowel diseases 14 (7), 1000-1011, 2008 | 168 | 2008 |
Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis MK Wendt, PA Johanesen, N Kang-Decker, DG Binion, V Shah, ... Oncogene 25 (36), 4986-4997, 2006 | 168 | 2006 |
Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells MK Wendt, AN Cooper, MB Dwinell Oncogene 27 (10), 1461-1471, 2008 | 158 | 2008 |
Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway N Balanis, MK Wendt, BJ Schiemann, Z Wang, WP Schiemann, CR Carlin Journal of Biological Chemistry 288 (25), 17954-17967, 2013 | 151 | 2013 |
The paradoxical functions of EGFR during breast cancer progression R Ali, MK Wendt Signal transduction and targeted therapy 2 (1), 1-7, 2017 | 144 | 2017 |
CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity JM Smith, PA Johanesen, MK Wendt, DG Binion, MB Dwinell American Journal of Physiology-Gastrointestinal and Liver Physiology 288 (2 …, 2005 | 109 | 2005 |
Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche A Shinde, JS Paez, S Libring, K Hopkins, L Solorio, MK Wendt Oncogenesis 9 (2), 16, 2020 | 107 | 2020 |
Spleen tyrosine kinase–mediated autophagy is required for epithelial–mesenchymal plasticity and metastasis in breast cancer A Shinde, SD Hardy, D Kim, SS Akhand, MK Jolly, WH Wang, ... Cancer research 79 (8), 1831-1843, 2019 | 104 | 2019 |
Autocrine fibronectin inhibits breast cancer metastasis A Shinde, S Libring, A Alpsoy, A Abdullah, JA Schaber, L Solorio, ... Molecular cancer research 16 (10), 1579-1589, 2018 | 100 | 2018 |
Selection of DNA-encoded libraries to protein targets within and on living cells B Cai, D Kim, S Akhand, Y Sun, RJ Cassell, A Alpsoy, EC Dykhuizen, ... Journal of the American Chemical Society 141 (43), 17057-17061, 2019 | 96 | 2019 |
Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia RA Moyer, MK Wendt, PA Johanesen, JR Turner, MB Dwinell Laboratory investigation 87 (8), 807-817, 2007 | 96 | 2007 |
p130Cas is required for mammary tumor growth and transforming growth factor-β-mediated metastasis through regulation of Smad2/3 activity MK Wendt, JA Smith, WP Schiemann Journal of biological chemistry 284 (49), 34145-34156, 2009 | 90 | 2009 |
TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer MK Wendt, BJ Schiemann, JG Parvani, YH Lee, Y Kang, WP Schiemann Oncogene 32 (16), 2005-2015, 2013 | 83 | 2013 |